Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

Dorothée Duluc(Inserm), Yves Delneste(Inserm), Fang Tan(Inserm), Marie‐Pierre Moles(Inserm), Linda Grimaud(Inserm), Julien Lenoir(Université d'Angers), Laurence Preisser(Inserm), Ignacio Anegón(Inserm), Laurent Catala(Centre Hospitalier Universitaire d'Angers), Norbert Ifrah(Centre Hospitalier Universitaire d'Angers), Philippe Descamps(Centre Hospitalier Universitaire d'Angers), Érick Gamelin(Inserm), Hugues Gascan(Inserm), Mohamed Hebbar, Pascale Jeannin(Inserm)
Blood
September 12, 2007
Cited by 473Open Access
Full Text

Abstract

Tumor-associated macrophages (TAMs), the most abundant immunosuppressive cells in the tumor microenvironment, originate from blood monocytes and exhibit an IL-10(high)IL-12(low) M2 profile. The factors involved in TAM generation remain unidentified. We identify here leukemia inhibitory factor (LIF) and IL-6 as tumor microenvironmental factors that can promote TAM generation. Ovarian cancer ascites switched monocyte differentiation into TAM-like cells that exhibit most ovarian TAM functional and phenotypic characteristics. Ovarian cancer ascites contained high concentrations of LIF and IL-6. Recombinant LIF and IL-6 skew monocyte differentiation into TAM-like cells by enabling monocytes to consume monocyte-colony-stimulating factor (M-CSF). Depletion of LIF, IL-6, and M-CSF in ovarian cancer ascites suppressed TAM-like cell induction. We extended these observations to different tumor-cell line supernatants. In addition to revealing a new tumor-escape mechanism associated with TAM generation via LIF and IL-6, these findings offer novel therapeutic perspectives to subvert TAM-induced immunosuppression and hence improve T-cell-based antitumor immunotherapy efficacy.


Related Papers